Company

PT Indofarma

Headquarters: Bekasi, Indonesia

Employees: 1,249

IDX: INAF

Market Cap

Rp390.51 Billion

IDR as of July 1, 2024

US$23.8 Million

Market Cap History

PT Indofarma market capitalization over time

Evolution of PT Indofarma market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of PT Indofarma

Detailed Description

PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company manufactures, trades in, and distributes medicine and medical devices; extracts and herbals; and operates laboratory. It also provides devices and health services for prevention, control, and treatment of COVID-19. The company also exports its products. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk is a subsidiary of PT Bio Farma.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

PT Indofarma has the following listings and related stock indices.


Stock: IDX: INAF wb_incandescent

Details

Headquarters:

Jalan Indofarma No. 1

Cikarang Barat

Bekasi, 17530

Indonesia

Phone: 62 21 8832 3975

Fax: 62 21 8832 3972